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AbstrACt
Objective To explore whether a preconsultation web-
based intervention enables patients with diabetes to 
articulate their agenda in a consultation in the hospital 
outpatient clinic with their diabetologist.
Methods and design A qualitative study embedded in a 
pragmatic pilot randomised controlled trial.
setting Two city outpatient departments in England.
Participants 25 patients attending a follow-up 
consultation and 6 diabetologists.
Intervention The PACE-D, a web-based tool adapted for 
patients with diabetes to use before their consultation 
to generate an agenda of topics to discuss with their 
diabetologist.
Data collection 25 participants had their consultation 
with their diabetologist audio-recorded: 12 in the control 
arm and 13 in the intervention arm; 12 of the latter also 
had their PACE-D intervention session and a consultation 
recorded. Semi-structured interviews with 6 diabetologists, 
and 12 patients (6 in the intervention group and 6 in the 
control group).
Analysis Thematic discourse analysis undertaken with 
patient representatives trained in qualitative data analysis 
techniques.
results We identified four consultation types: 
diabetologist facilitated; patient identified; consultant 
facilitated and patient initiated and patient ignored. We 
also identified three critical aspects that explained the 
production and utilisation of the agenda form: existing 
consultative style; orientation to the use of the intervention 
and impact on the consultation. Where patients and 
diabetologists have a shared preference for a consultant-
led or patient-led consultation, the intervention augments 
effective communication and shared decision making. 
However, where preferences diverge (eg, there is a 
mismatch in patients' and diabetologists' preferences 
and orientations), the intervention does not improve the 
potential for shared decision making.
Conclusion A simple web-based intervention facilitates 
the articulation of patients’ unvoiced agenda for a 
consultation with their diabetologist, but only when 
pre-existing consultation styles and orientations already 
favour shared decision making. More needs to be done to 
translate patient empowerment in the consultation setting 
into genuine self-efficacy.
trial registration number ISRCTN75070242.
IntrODuCtIOn
By 2045, 693 million people (aged 18–99 
years) worldwide will have diabetes, with 
global healthcare expenditure for diabetes 
expected to increase by 7% from 2017 to 
US$958 billion.1 Diabetic complications are 
associated with substantial long-term health-
care costs, now rising steadily over time.2 
Diabetes is largely monitored and managed 
by patients themselves.3 Self-management 
involves complex self-care tasks, which may 
place a burden on those with diabetes, which 
can inhibit effective self-care.4 Advice from 
professionals is vital to self-management, 
improving patients’ ability to cope with their 
illness.5 Effective consultations are associ-
ated with empowerment, positive behaviour 
change and improved diabetes outcomes.6–8 
However, there is a lack of consensus among 
clinicians about the format of diabetes 
reviews9 and patients’ concerns are often 
overlooked.10 11 Thus, methods to improve 
the quality of consultations in terms of the 
ability of the patient to discuss their concerns, 
understand information and remember and 
follow advice are consistently sought.
strengths and limitations of this study
 ► Patients were involved at all stages of the develop-
ment of the intervention and its evaluation.
 ► This qualitative study sampled patients and cli-
nicians who had participated in both arms of a 
randomised controlled trial of an intervention con-
ducted at two hospital sites.
 ► A strength of the study is the use of multiple sourc-
es of qualitative data, collected from preconsulta-
tion intervention sessions, patient-diabetologist 
consultations, agenda forms and postconsultation 
interviews.
 ► A limitation was the number of participants recruited 
to the trial, which limited the sampling available for 
the qualitative study.
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Methods used to improve consultations include 
question checklists and patient coaching delivered 
immediately before consultations. Information-seeking 
behaviour and patient satisfaction are most improved by 
combining coaching with written material.12 A system-
atic review of computer-based self-management inter-
ventions for adults with type 2 diabetes identified 16 
randomised controlled trials, but was unable to discern 
the active ingredients or optimal ‘dose’ of the inter-
ventions.13 Previously, Greenfield et al used a medical 
record review, a treatment algorithm and a behaviour 
change strategy, to improve both patient participation 
in the consultation and glycaemic control.14 Subse-
quently, Cegala et al have suggested that communication 
skills training for patients can enhance their participa-
tion in the medical consultation.15 They have proposed 
the Presenting Asking Checking Expressing (PACE) 
system for patients to develop effective communication; 
this involves patients presenting detailed information 
about how they are feeling, asking questions if desired 
information is not provided, checking understanding 
of information that is given to them and expressing 
any concerns about the recommended treatment. We 
modified the PACE system specifically for diabetes to 
produce a web-based tool (PACE-diabetes or PACE-D), 
designed to be completed by a patient immediately 
before a clinic appointment with a diabetologist to 
identify the issues that they wish to discuss with them 
(ie, their ‘agenda’—figure 116 17 and online supplemen-
tary file).
The aim of this paper is to explore whether a preconsul-
tation web-based intervention enables patients to articu-
late their agenda in a consultation with their diabetologist.
MethODs
Design
A qualitative study embedded in a pragmatic pilot 
randomised controlled trial.16
Participants and study setting
For the trial, we aimed to recruit 120 patients attending 
diabetes clinics at two outpatient departments in England. 
Eligible patients were adults with type 1 or type 2 diabetes 
who were due to attend outpatient appointments with 
their diabetologist. Participants were aged 18 years or 
over with basic spoken or written English, necessary to 
complete the outcome measures. Pregnant women with 
diabetes and patients with diabetes receiving insulin 
pump therapy were excluded as they attended separate 
designated clinics for those conditions.
recruitment
Potential participants were identified from clinic lists 
of participating consultant diabetologists by a research 
nurse at each location. Those who expressed an interest 
were sent a Patient Information Sheet, and telephoned 
a week later by a research nurse who established their 
willingness to participate, and sent them a Consent Form 
and baseline questionnaires. On receipt of these docu-
ments, participants were randomised to either the inter-
vention or usual care. Because patients were added to the 
clinic list later than anticipated, with ethical approval this 
process was condensed to facilitate recruitment.17
Intervention
In a 20 min session immediately preceding the clinic 
appointment, a trained healthcare assistant (HCA) 
assisted the patient to complete the web-based form 
(figure 1).
The patients in the intervention arm proceeded to the 
clinical consultation with the printout of their interven-
tion form which they handed to the diabetologist, and 
which then acted as an agenda for their consultation. Due 
to the nature of the intervention and the production of 
an agenda, it was impossible to blind health professionals 
or patients to trial allocation.
Control
This comprised usual clinical care provided by the same 
diabetologists in outpatient clinics.
Data collection
We planned to audio-record 10 intervention sessions, to 
explore how patients used the web-based intervention 
and the amount of assistance that they required from 
Figure 1 Agenda form for Mrs Edwards.
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the HCA. We also planned to audio-record 30 clinical 
consultations across both trial arms and study sites, to 
understand the mechanisms that underlie the impact of 
the production of an agenda on the clinical consultation, 
and its subsequent utilisation in practice, when compared 
with usual care.18 19 As patients, rather than diabetologists 
were randomised, we sought to explore the impact on 
diabetologists’ conduct, by comparing ‘naturally occur-
ring’ data for consultations with patients in the control 
arm (to establish the natural ecology of conversations), 
and research generated data (from use of the agenda 
form in the intervention arm) for each diabetologist.20 21
We also aimed to conduct semi-structured interviews 
with a purposive sample of 5 clinical staff and 10 patients 
in each trial arm to explore wider organisational factors. 
All data were transcribed and anonymised, and managed 
using Nvivo software.
Analysis
Data analysis began with a preliminary charting exercise 
(JF, CA), first of consultations from the control arm and 
subsequently for those in the intervention arm, which 
allowed us to typify usual care and subsequently to iden-
tify any relationships between the process of agenda iden-
tification and agenda use.22 From the charting exercise, 
we identified a preliminary typology of consultations 
(patient ignored, consultant led, patient led, consultant 
and patient led). AG, NB and JF then trained a group 
of four patient and public involvement (PPI) represen-
tatives, including the two PPI co-applicants (see below), 
in qualitative data analysis techniques.23 The PPI group 
developed the preliminary typology—identifying the 
terms ‘patient identified’ (rather than ‘patient led’) and 
‘diabetologist facilitated’ (rather than ‘consultant led’) as 
more nuanced. For example, a consultation was defined 
as patient initiated and diabetologist facilitated, when the 
doctor brought his agenda into play but he interweaved 
it into the patient’s agenda. These discussions were incor-
porated into a coding manual that defined each of the 
four categories, and which was used to further analyse 
the data and develop display matrices for each category 
(JF, LM).24 Both coders independently coded the dataset 
on the basis of those categories, and the small number 
of disagreements were resolved by discussion (eg, revis-
iting the discussions with the PPI group). By applying this 
typology to the whole dataset, including the agenda forms, 
field notes and interviews with patients and physicians, we 
sought to identify explanatory factors which mediated the 
production and utilisation of an agenda form. Completed 
matrices for the whole dataset were then discussed again 
with the PPI group, who confirmed the analyses.
Patient and public involvement
Patients identified the research question and were 
involved in the design and conduct of the research and 
dissemination of findings.16 With patient input, a project 
team was convened and a scoping exercise undertaken 
to assess what is known about the problem. Two patient 
representatives who have diabetes joined the research 
team as co-applicants on this proposal. Supported by a 
designated PPI research fellow (AG), these patient co-ap-
plicants were members of the project management team, 
who co-wrote the study documentation (including Patient 
Information Sheets and interview guides), assisted with 
training the HCAs, and participated in the data analysis.25 
A further group of eight people with diabetes provided 
feedback on a prototype of the intervention.
results
Fifteen diabetologists working at the two centres were 
approached. Nine consented to participate and were 
formally inducted to the study in terms of the use of the 
agenda form, ethical practice and trial procedures. Patients 
were screened for eligibility (n=395). Of those who were 
eligible for the trial (n=380), 71 were recruited to the 
study, with 38 participants randomised to the intervention 
arm and 33 to the control arm (table 1). Participants were 
similar to eligible non-participants with respect to mean 
Table 1 Patient characteristics
Characteristics Control Intervention
Full sample n=33 n=38
  Centre (Moorland/Parkview), 
n
15/18 15/23
  Type of diabetes (1/2), n 24/9 23/15
  Age (years), mean 57.8 55.3
  Gender (male/female), n 18/15 19/19
  Ethnicity (white/other/
missing), n
28/2/3 27/2/9
  Insulin (yes/no/missing), n 30/1/2 27/5/6
  Oral medications (yes/no/
missing), n
15/16/2 17/15/6
  First HbA1c (mmol/mol), 
mean
68.9 (n=30) 71.0 (n=29)
Qualitative subsample n=12 n=13
  Centre (Moorland/Parkview), 
n
2/10 3/10
  Type of diabetes (1/2), n 6/6 8/5
  Age (years), mean 57.3 56.5
  Gender (male/female), n 6/6 7/6
  Ethnicity (white/other/
missing), n
12/0/0 12/1/0
  Insulin (yes/no/missing), n 9/1/2 9/2/2
  Oral medications (yes/no/
missing), n
8/2/2 7/4/2
  First HbA1c (mmol/mol), 
mean
78.2 (n=12) 78.5 (n=12)
Insulin—any baseline with an injection. Oral—any baseline with a 
tablet medication. HbA1c—the first result only is taken. Missing—
no questionnaire returned.
HbA1c, glycated haemoglobin.
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(SD) age at registration (56.5 (12.4) vs 51.3 (16.1)), type 
1 (as opposed to type 2) diabetes status (66.2% vs 60.5%) 
and whether attending for a new appointment (4.2% vs 
8.1%). With consent, 25 participants had their consul-
tation with their diabetologist audio-recorded: 12 in the 
control arm and 13 in the intervention arm. Twelve of the 
latter had both their intervention session and consulta-
tion recorded. JF, an experienced qualitative researcher, 
then conducted semi-structured interviews with a purpo-
sive sample of 6 diabetologists, and 12 patients (6 in each 
trial arm) to contextualise our understanding. Patient 
interviews were conducted at their homes while all diabe-
tologists except one were interviewed in the clinic. Inter-
views lasted between 20 and 60 min, and JF made field 
notes afterwards. All participants and clinics were given 
pseudonyms in line with in line with the principles of the 
Declaration of Helsinki,26 and the International Confer-
ence on Harmonisation-Good Clinical Practice.27
Applying the PPI groups’ typology to the wider dataset 
enabled us to identify the key aspects that explained the 
production and utilisation of an agenda form: existing 
consultative style; orientation to the use of an agenda 
form and, ultimately, the impact on the consultation.
existing consultative style
In the control group we were able to identify each diabe-
tologists’ usual style for eliciting information. For some 
this involved checking each medication and whether 
routine screening has been undertaken rather than asking 
patients about their concerns, while for others an open 
question was sufficient to set the tone of the consultation:
So can I start by double checking some stuff with you, 
is that all right? And we’ll get on to what you want. 
(Mrs Brown, 49 years/Dr Smith, Parkview, control 
group consultation)
How do you think things are? I mean, have you had 
any particular problems over the last month or two, 
or do you think it’s fairly stable and under reasonable 
control? (Mr Wilson, 79 years/Dr Jones, Parkview, 
control group consultation)
Unsurprisingly, this continuum is evident in the inter-
vention group, with some diabetologists using their 
existing script prior to facilitating use of the agenda form, 
while others use the agenda form instead of their usual 
open questioning:
So you very kindly agreed to take part in the study…
Fantastic. And you’ve gone through that (Agenda) 
before, and we’re going to be using this as the ba-
sis for the consult today… (Miss Roberts, 52 years/
Dr Smith, Parkview intervention group consultation)
We found no evidence of contamination between 
consultations in the intervention arm and the control 
arm (ie, there were no examples of physicians changing 
what they did in usual practice as a result of participating 
in the trial). Rather, we identified that the diabetologists’ 
consultative style endured despite the use of an agenda 
form, with the agenda form acting as a magnifier of 
existing consultative style rather than as a mediator.
Patient experiences of participating in a diabetes 
consultation varied considerably. In some consultations, 
we were able to discern much that is literally unsaid or 
shorthand, where both parties knew the broader context, 
due to their ongoing relationship:
I’ve known her now for well over twenty years, and 
she has been nothing but nice, and stern if I’ve been 
naughty, you know, which is fair enough…And what 
it does, it makes me more enthusiastic to look after 
my diabetes. I go away feeling better and saying ‘Well, 
I must improve on that and must do this’. Be nice if 
she could do it every fortnight that would be even bet-
ter! (Mrs Johnson, 70 years, Moorland, control group 
interview)
In other consultations, agenda items were discussed at 
length, with the diabetologist using this as an opportu-
nity to educate, inform or reassure their patients. Where 
people with diabetes and their diabetologist have a posi-
tive pre-existing relationship and share the same orienta-
tion to decision making (eg, both have a preference for 
either the diabetologist or the patient leading the consul-
tation), the agenda form augments existing relationships 
and mutual information sharing styles:
She’s always interested in my view and respects my 
view, um, ‘cause we both know that I’ve been told that 
I can’t be cured and it’s just prophylactic care….And 
she’s said to me ‘If you think I’m trying to ask you to 
do things that is too much for you, you just say, and 
that. Um, due to the fact that she’s also very, very in-
terested in my illness. (Miss Clarke, 50 years, Parkview 
intervention group interview)
Where relationships are weaker and there is dissonance 
in information exchange (due to lack of an existing rela-
tionship or lack of agreed orientation), the agenda form 
amplifies existing tensions:
I saw (diabetologist). At the end of the consultation 
he said to me, erm, you have 10 s is there anything 
else you would like to ask me which I thought was, 
you know, ha ha ha…couldn’t believe it, I was so gob 
smacked… I just walked out you know….Well he 
seemed very arrogant to me. (Mr Martin, 74 years, 
Moorland, intervention session)
Orientation to the use of the intervention
Consultative styles were not distributed equally across 
our typology. Most consultations had some examples of 
shared decision making (ie, patient led or diabetologist 
facilitated), with fewer examples of interactions that were 
either explicitly consultant led, or where the patients’ 
agenda remained unvoiced or was ignored.
Despite participating in the study, two diabetologists 
did not embrace the philosophy of the project:
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I discuss the issues but I tend to find that I don’t get 
answers that I, that I want…Yeah, maybe the doctor’s 
got a different opinion about it, but I would like to 
see results and I don’t see the results… there’s al-
ways a different answer coming back to me from the 
um, the diabetic doctor… maybe I’ve got one way of 
thinking and he’s got a different way, you know. And 
when I said to him, you know, ‘What about an insu-
lin pump, would that help?’ ‘Oh well, yeah, but you 
wouldn’t, it wouldn’t be any good for you’ and that’s 
it, you know, nothing’s tried. (Mr Wright, 52 years, 
Parkview, control group interview)
Two patients in the intervention arm were prevented 
from using the agenda as intended. Dr Smith wrongly 
believed that the intervention was making the clinic run 
over, and Miss Taylor was prevented from completing the 
intervention, to ensure that the clinic was not affected. 
Another patient, Mr Davies, reported that he was told 
by Dr Green to ‘put the agenda form in his backpack’ 
because it was not needed. Although both instances may 
be due to misperceptions about the impact of the study 
on clinic waiting times,17 evidence from the consultations 
suggests that both of these diabetologists typically favour 
a more consultant-led style of consultation:
I don’t think the agenda improved it at all, it may 
have been slightly useful for her but from my per-
spective we discussed two things that weren’t relevant 
to diabetes. So I was doing a general practitioner role 
and we over ran by about 10 min as a result so I have 
considered that a negative experience on my behalf, 
but she may have liked it. (Dr Smith, Moorland, mes-
sage left for researchers on audio-recorder).
Some patients did not produce their own agenda (eg, Mr 
White), and took blank forms to consultations, suggesting 
to the HCA that they did not have any concerns or that 
they were satisfied with how the diabetologist conducted 
the consultation.
In contrast, there were more diabetologists with a more 
facilitative predisposition, who embraced the ethos of the 
agenda form, and permitted patients to set the agenda 
for the consultation, even if this led to patients discussing 
unrelated issues:
I seem to remember one of the questions that they 
asked … it was really off the wall, as in it was really 
not really at all relevant in terms of their care… it 
introduced new topics that I wouldn’t have brought 
up myself and they might not have otherwise done…
And they say this all the time ‘Is this something I can 
discuss here or is this something I should discuss with 
the GP?’ (Dr Williams, Moorland, interview)
Well, I thought it was, one of the reasons I was inter-
ested in the study was ‘cause I am concerned, so—my 
background to this is I watch my friends who’ve all 
become GPs, get trained in consultation skills and 
how to set up consultations …And since some of the 
principles of the study involved sort of setting up a 
patient agenda and maybe an alternative way of tack-
ling a consultation that improved patients well-being, 
might potentially improve patient engagement with 
that process … (Dr Thomas, Parkview, interview)
Patients who engaged with the intervention highlighted 
presuggested issues and/or used the form to write their 
own list of questions or concerns —with only some high-
lighting the three most important issues as instructed. 
The most common agenda item was medication and 
insulin management specifically.
I think (the agenda form) was good idea… ‘cause I 
must admit I go down to the doctors’ and you go on 
to one thing and then suddenly summat’ll be said 
and then they go off in a direction and then you’ve 
got to try and get back on to what you want to talk 
about….we just went through the agenda, basically, 
you know, we’d talk about this, what are you doing, 
where’s your weight, you know, what’s your sugar 
levels and everything else… (Mr Hughes, 55 years, 
Parkview, intervention group interview)
Impact on the consultation
Having identified the significance of existing consulta-
tive styles and orientations, we then explored how they 
related to the PPI identified typology and the use of an 
agenda form:
Patients were ignored when, despite completing an agenda 
form, the diabetologist stuck to their regular script and 
conducted business as usual. These diabetologists often 
declined to have their consultations recorded, despite 
the patient consenting, and information was thus gath-
ered from observations and conversations in the clinic, 
or by interview with the patient at home. For example, 
this patient had three questions on her agenda form but 
perceived that she has still not been able to discuss them 
(figure 1):
Well, what I mean is probably I don’t talk. I can’t talk 
about the impact on my life, like you’ve asked me to-
day (in the qualitative interview) mostly it’s all inter-
nalised in my head, my experiences of diabetes. (Mrs 
Edwards, 76 years, Moorland, intervention group 
interview)
Consultations were consultant facilitated when the diabe-
tologist stuck to their pre-existing script or maintained 
business as usual despite the participant writing a list of 
concerns. In this example, the diabetologist focused on 
the patients’ perceived lack of understanding rather than 
their agenda:
D: Since the exenatide hasn’t worked I don’t have an-
other treatment that will help your diabetes and also 
cause weight loss or isn’t any other treatment we have. 
So insulin is what we have to go with, okay and your 
blood sugar levels have been very high, and I can see 
from that blood test they have been worryingly high 
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so I would say to you that we do need to increase the 
insulin dose and in fact get your blood sugars down.
P: By how much, you know?
D: I don’t know, so be clear just try that, bear with me 
sir, please bear with me. I don’t know now how much 
insulin you will need, so some people need…
P: How is that you can be so certain that exenatide 
is not doing me any good… yet you failed to tell me 
what dose I should be taking of insulin.
D: I think you should just listen and I will answer that 
question for you… With insulin different people have 
hugely different requirements so some people take 
20 units a day, some people might take several hun-
dred units in a day, okay. So if I look at you and you 
say to me, how much insulin do I need? The answer 
is I do not know how much insulin but we have a way 
of finding out, so the answer is we increase the dose, 
until your blood sugars come down, so otherwise this 
case would increase, an increase until we get the dose 
right, okay.
P: But by how much?
D: That is something I can’t tell you, I am just 
explaining.
 ► (Mr Martin, 74 years/Dr Smith, Moorland, interven-
tion group consultation)
 ► Mr Martin and Dr Smith had an established rela-
tionship, and we found no evidence that having an 
enduring relationship in itself was a guarantee of 
agenda facilitation. Nor did we find evidence that the 
age of the patient determined either their desire or 
experience of shared decision making, although we 
acknowledge that due to recruitment challenges our 
sample was small.
Consultations were consultant facilitated and patient initi-
ated when pre-existing relationships were positive and/
or the ethos of shared decision making was embraced. 
In this example, the participant had recently been diag-
nosed with dementia and attended the clinic with his wife 
who was his carer. They identified 12 concerns, and the 
diabetologist focused on his primary concern, which was 
tiredness:
D: Good to have (your) concerns. Right, OK. Right, 
nice to see you again.
P: Yes.
D: It’s been a little while hasn’t it… Since I saw you 
last time. … Yeah, how are you anyway, bring me up 
to date
P: Going down really, aren’t I?… I was getting so tired, 
very tired, you know, got no energy at all. I don’t know 
that’s the diabetes or the, um…
D: So that’s still the main concern, really, from your 
end of the line, this fatigue, we just haven’t really got 
on top of that….
P: … Oh yes, just been diagnosed with dementia as 
well, the start of dementia…
D: You have?
P: Vascular dementia…
D: How did that come about?
P: Um, it’s just my GP, we were talking to the GP and 
I was saying I was beginning to forget a lot of things 
and she did a few tests and um, said ‘Yeah, it looks as 
though you are’ and she sent me off to see a specialist 
in (place)…
D: Have you stopped any treatment that you were on, 
or are you basically finding you still need all the same?
P: I still need all the same stuff…
D: Right. Um, there’s a few things I suspect we need 
to chat about today. Were there any other specific 
concerns that you had at this point?
P: Not really, no…
D: That’s the general issue. (Mr Lewis, 74 years/
Dr Smith, Parkview, intervention group consultation)
Few consultations were patient identified. This tended to 
occur when patients had greater material advantage, for 
example, they were a health professional with a similar 
repertoire of knowledge, long-standing patients who were 
competent at self-management, or a new patient already 
versed in shared decision making. In this example, a new 
patient, who had recently returned to the UK from living 
overseas, was able to articulate a range of concerns for the 
diabetologist to address:
D: Can I ask you, you’ve gone through an agenda be-
fore you came in this morning, what were the areas of 
concern that, um, you wanted to discuss today?
P: Well, I think now that I’ve basically on the insulin 
and getting my diabetes organised is the neuropathy 
that’s of most concern right now.
D: So there’s …
P: It’s affecting my lifestyle to such an extent, I’m not 
sleeping. Because I walk every day, I mean, you have 
to walk, but it’s just um, I mean, I like to do all the 
travelling and walking and I’m concerned about it, 
how it’s going to affect my lifestyle.
D: How is it affecting you currently? So what symp-
toms does your neuropathy give you currently?
P: Er, a lot of pain, aching, deep ache….
D: OK. Apart from pain, does it affect you any other 
way? Is pain the main feature at the moment, is it that 
when you’re walking you’re unsteady at all, or…?
P: Yeah, my balance has been affected, yes.
D: OK. So there’s your neuropathy, concern number 
one. Were you saying that your diabetes, just levelling 
out your glucose levels, your glucose values, was also 
a concern to you, getting those optimised, is that part 
of your…?
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P: Oh obviously, it’s going to, yeah, that’s a major con-
cern, yeah, just getting those level, get it right, diet 
organised, those levelled out and just the feeling of 
being, I feel like I’ve got the ‘flu' all the time, just 
tired.
D: You’re tired, OK.
P: Just tired all the time. So, I mean, I don’t know 
whether there’s any health things, I haven’t had a 
complete health check-up for years, so, I mean, it’s 
just really difficult.
D: OK, but those are the … are there any other areas 
you want to bring up today, or are those the three?
P: No, those are the three, yeah. (Mrs Harris, 
65 years/Dr Thomas, Parkview, intervention group 
consultation)
In the wider transcript of the consultation, Mrs Harris 
suggests that her motivation for asking questions was the 
differing experiences of diabetes provision that she expe-
rienced in both North America and Australia, and her 
recent diagnosis of neuropathy, which she interpreted as 
a sign of deterioration.
DIsCussIOn
The principal finding is that where patients and diabe-
tologists have a shared preference for a consultant-led or 
patient-led consultation the PACE-D augments effective 
communication and shared decision making. However, 
where preferences diverge PACE-D does not improve the 
potential for shared decision making (ie, concerns could 
remain unvoiced or ignored). The trial design allowed 
us to compare individual consultative styles across arms, 
outpatient settings and between cases. The majority of 
patients who completed the PACE-D found the interven-
tion acceptable, and suggested that it helped them to 
think about issues related to their care.17 Our qualitative 
findings provide insights into how an agenda form may 
(or may not) function in medical consultations where 
patient concerns are often discounted.28 29
Our findings support those of previous research that 
used a single exposure intervention for prioritising diabe-
tes-related treatment goals30: PACE-D did not universally 
improve patient empowerment, but acted as a magnifier 
for pre-existing consultative styles and orientations. Our 
findings are similar to those of Rhodes et al who identified 
that at worst, patients can experience ‘industrialisation’ 
of diabetes care whereby their concerns are diminished 
by the demands of the clinic, while at best the clinician 
can use the introduction of an intervention as an oppor-
tunity to practise patient-centred care.31 Key challenges 
that we identified include: lack of resources in the outpa-
tient setting (including lack of time and space for an 
intervention) and lack of buy-in from clinicians despite 
consenting to participate. Any future research would 
need to give these contextual factors greater consider-
ation in the designing and planning stages.
A limitation of this study is that although we planned 
recruitment of 120 participants, only 71 participants were 
randomised during the 7-month recruitment period, 
and only half agreed to participate in this qualitative 
study. We have previously identified that a randomised 
controlled trial of the preconsultation web-based inter-
vention as set out in our current protocol is not feasible 
without significant modification to improve recruitment 
and follow-up of participants.17 However, triangulating 
data from interventions sessions, consultations, agenda 
forms and interviews allowed us to identify the extent 
to which individual patient concerns were addressed in 
a given consultation.23 As a recent systematic review of 
interventions to improve health outcomes arising from 
patient-clinician encounters failed to include trials that 
sought to explicitly empower patients,31 our findings 
suggest that more now needs to be done to explore 
which interventions patients consider to be most effec-
tive at addressing their concerns.
A strength of this study is the participation of patient 
representatives at all stages of the study enabled them 
to make a valuable contribution to our understanding 
of intervention development and implementation. We 
concluded that it would not be appropriate to run a 
definitive randomised controlled trial without amending 
our intervention in order to optimise the elicitation and 
utilisation of the patients’ agenda.
COnClusIOn
A simple web-based intervention can facilitate the articu-
lation of patients’ unvoiced agenda for a consultation with 
their diabetologist, but only when pre-existing consulta-
tion styles and orientations already favour shared deci-
sion making. More needs to be done to translate patient 
empowerment in the consultation setting into genuine 
self-efficacy.
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